Villamayor Capital
Contributor since: 2018
Latest Articles
Pyxus May Not Convert Itself Into A Marijuana Seller
Is The New Cannabis Payment Solution Of Net Element An Opportunity?
Proteostasis Therapeutics Delivered 400% Stock Returns
Yulong Eco-Materials: 1,000% Stock Returns
SolarWinds: Thoma Bravo And Silver Lake Are Selling Shares At An Expensive Price
Axsome Therapeutics: Several Candidates At Phase 3
Altimmune Declines Too Much
Why Did DAVIDs TEA Say No To Marijuana Producers?
India Globalization Capital: Be Very Careful With The Stock
Cannabis Play: New Age Beverages Corporation Seems Undervalued
Overvalued Titan Pharmaceuticals Sells Convertible Securities
Cronos Group: Fantastic Business But Seems Very Overvalued
Citron Pushes Down CV Sciences. Does It Make Sense?
BTCS: Buying Bitcoin And Ethereum Will Not Help If Share Count Keeps Increasing
500.Com Has A Solid Business Model That Seduced Even Sequoia Capital, But The Shares Are Quite Expensive.
Safe Bulkers: 8% Yielder That Looks Quite Appealing On The Surface
KCAP Financial, Appealing Yield Of 12.46% And Discount To NAV At 34%? Be Careful
Risky Horizon Technology: Discount Of 13% To Net Asset Value And Dividend Yield Of 11.76%
Garrison Capital: Discount To Net Asset Value Of 23% And Forward Yield Of 13.33%
Risky Capitala Finance: Dividend Yield Of 12.03% And Trading At 59% Of Its NAV Per Share
Hui Ying Financial IPO: Low Float, But 88% Revenue Growth
Abaxis May Not Receive A New Offer
Scholar Rock IPO: I Will Wait Until 2020
IPO Of Evo Payments: The Goodwill Represents An Opportunity